Elham F. Steiner

David E. Moore

Bindu Ann George Palapura

Douglas H. Carsten

David M. Hanna

Kristina A. Hanson

David T. Pritikin

Dov P. Grossman

Lisa A. Schneider

Jack B. Blumenfeld

Derek J. Fahnestock

Bruce R. Genderson

Adam L. Perlman

Bindu Donovan

Rodger D. Smith, II

S. Isaac Olson

Kathryn Kayali

Alexander S. Zolan

Martha C. Kidd

ANDA filing triggers Bayer-Janssen suit to block generic XARELTO®, alleging Mylan infringes its patent on `no more than once daily` anticoagulant dosing.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Janssen Pharmaceuticals Inc

Mylan Pharmaceuticals Inc

Bayer Intellectual Property GmbH

Bayer AG

Last Docket Entry Date

Total Docket Entries

United States District of Delaware

1:17-cv-00584 | Bayer IP GmbH v. Mylan Pharma Inc | Ex Parte

Judge	Period	PO Win Rate
Timothy B. Dyk	09/02/20 - 09/04/20	20%
Richard G. Andrews	09/01/17 - 09/02/20	37%

Name	Ratings
Bayer Intellectual Property GmbH	L5 A
Janssen Pharmaceuticals Inc	L5 A
Bayer AG	L5 A

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5 A
Jack B. Blumenfeld	L5 A
Derek J. Fahnestock	L5 A
Rodger D. Smith, II	L5 A
Sidley Austin LLP	L5 B
David T. Pritikin	L5 B
Lisa A. Schneider	L4 B
Bindu Donovan	L4 E
S. Isaac Olson	L2 C
Williams & Connolly LLP	L3 B
Adam L. Perlman	L5 A
Bruce R. Genderson	L5 A
Dov P. Grossman	L4 A
Alexander S. Zolan	L1 B
Martha C. Kidd	L1 B
Kathryn Kayali	L1 C

Name	Ratings
Potter Anderson & Corroon LLPLocal	L5 A
David E. Moore	L5 A
Bindu Ann George Palapura	L5 A
Wilson Sonsini Goodrich & Rosati	L5 B
Elham F. Steiner	L3 B
Douglas H. Carsten	L3 E
David M. Hanna	L1 D
Kristina A. Hanson	-- -- --